These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26404264)

  • 1. Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis.
    Wu P; van den Berg C; Alfirevic Z; O'Brien S; Röthlisberger M; Baker PN; Kenny LC; Kublickiene K; Duvekot JJ
    Int J Mol Sci; 2015 Sep; 16(9):23035-56. PubMed ID: 26404264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
    Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
    BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
    Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
    J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women.
    Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E
    Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels.
    Zwahlen M; Gerber S; Bersinger NA
    Gynecol Obstet Invest; 2007; 63(1):15-21. PubMed ID: 16864982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM 12 and PAPP-A at 14-17 weeks' gestation as biomarkers of pre-eclampsia.
    D'Anna R; Baviera G; Giordano D; Russo S; Santamaria A; Granese R; Corrado F
    Prenat Diagn; 2011 Jun; 31(6):602-4. PubMed ID: 21413042
    [No Abstract]   [Full Text] [Related]  

  • 9. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia.
    Vandenberghe G; Mensink I; Twisk JW; Blankenstein MA; Heijboer AC; van Vugt JM
    Prenat Diagn; 2011 Oct; 31(10):955-61. PubMed ID: 21717483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis.
    Zhu XL; Wang J; Jiang RZ; Teng YC
    Ann Med; 2015; 47(5):414-22. PubMed ID: 26153822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of first trimester biochemical markers and mean arterial pressure in prediction of early-onset pre-eclampsia.
    Nevalainen J; Korpimaki T; Kouru H; Sairanen M; Ryynanen M
    Metabolism; 2017 Oct; 75():6-15. PubMed ID: 28964327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
    Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
    Giguère Y; Massé J; Thériault S; Bujold E; Lafond J; Rousseau F; Forest JC
    BJOG; 2015 Feb; 122(3):402-10. PubMed ID: 25175335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
    Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia.
    Di Lorenzo G; Ceccarello M; Cecotti V; Ronfani L; Monasta L; Vecchi Brumatti L; Montico M; D'Ottavio G
    Placenta; 2012 Jun; 33(6):495-501. PubMed ID: 22459245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum placental growth factor, pregnancy-associated plasma protein-a and free β-human chorionic gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia.
    Lai J; Pinas A; Poon LC; Agathokleous M; Nicolaides KH
    Fetal Diagn Ther; 2013; 33(3):164-72. PubMed ID: 23445908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.